213 related articles for article (PubMed ID: 28277487)
1. Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial.
Wohl DA; Golin CE; Knight K; Gould M; Carda-Auten J; Groves JS; Napravnik S; Cole SR; White BL; Fogel C; Rosen DL; Mugavaro MJ; Pence BW; Flynn PM
J Acquir Immune Defic Syndr; 2017 May; 75(1):81-90. PubMed ID: 28277487
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV Viremia.
DiPrete BL; Pence BW; Golin CE; Knight K; Flynn PM; Carda-Auten J; Groves JS; Powers KA; White BL; Napravnik S; Wohl DA
AIDS Behav; 2019 Sep; 23(9):2386-2395. PubMed ID: 30963321
[TBL] [Abstract][Full Text] [Related]
3. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial.
Wohl DA; Scheyett A; Golin CE; White B; Matuszewski J; Bowling M; Smith P; Duffin F; Rosen D; Kaplan A; Earp J
AIDS Behav; 2011 Feb; 15(2):356-64. PubMed ID: 21042930
[TBL] [Abstract][Full Text] [Related]
4. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
[TBL] [Abstract][Full Text] [Related]
5. Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV care.
Golin CE; Knight K; Carda-Auten J; Gould M; Groves J; L White B; Bradley-Bull S; Amola K; Fray N; Rosen DL; Mugavaro MJ; Pence BW; Flynn PM; Wohl D
BMC Public Health; 2016 Sep; 16(1):935. PubMed ID: 27596559
[TBL] [Abstract][Full Text] [Related]
6. A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy.
Orrell C; Cohen K; Mauff K; Bangsberg DR; Maartens G; Wood R
J Acquir Immune Defic Syndr; 2015 Dec; 70(5):495-502. PubMed ID: 26218411
[TBL] [Abstract][Full Text] [Related]
7. Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia.
Bazazi AR; Culbert GJ; Wegman MP; Heimer R; Kamarulzaman A; Altice FL
BMC Infect Dis; 2022 Nov; 22(1):837. PubMed ID: 36368939
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of a Peer Navigation Intervention to Sustain Viral Suppression Among HIV-Positive Men and Transgender Women Released From Jail: The LINK LA Randomized Clinical Trial.
Cunningham WE; Weiss RE; Nakazono T; Malek MA; Shoptaw SJ; Ettner SL; Harawa NT
JAMA Intern Med; 2018 Apr; 178(4):542-553. PubMed ID: 29532059
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analyses on initiation, adherence and outcomes of antiretroviral therapy in incarcerated people.
Fuge TG; Tsourtos G; Miller ER
PLoS One; 2020; 15(5):e0233355. PubMed ID: 32421754
[TBL] [Abstract][Full Text] [Related]
10. Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study.
Westergaard RP; Hochstatter KR; Andrews PN; Kahn D; Schumann CL; Winzenried AE; Sethi AK; Gangnon RE; Sosman JM
AIDS Behav; 2019 Sep; 23(9):2549-2557. PubMed ID: 30790170
[TBL] [Abstract][Full Text] [Related]
11. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
12. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
[TBL] [Abstract][Full Text] [Related]
13. Use of an mHealth Intervention to Improve Engagement in HIV Community-Based Care Among Persons Recently Released from a Correctional Facility in Washington, DC: A Pilot Study.
Kuo I; Liu T; Patrick R; Trezza C; Bazerman L; Uhrig Castonguay BJ; Peterson J; Kurth A; Beckwith CG
AIDS Behav; 2019 Apr; 23(4):1016-1031. PubMed ID: 30627850
[TBL] [Abstract][Full Text] [Related]
14. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: Findings from a pragmatic randomized controlled trial in South Africa.
Hanrahan CF; Schwartz SR; Mudavanhu M; West NS; Mutunga L; Keyser V; Bassett J; Van Rie A
PLoS Med; 2019 May; 16(5):e1002808. PubMed ID: 31112543
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.
Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC
MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322
[TBL] [Abstract][Full Text] [Related]
16. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals.
Stephenson BL; Wohl DA; Golin CE; Tien HC; Stewart P; Kaplan AH
Public Health Rep; 2005; 120(1):84-8. PubMed ID: 15736336
[TBL] [Abstract][Full Text] [Related]
17. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865
[TBL] [Abstract][Full Text] [Related]
18. Health status, sexual and drug risk, and psychosocial factors relevant to postrelease planning for HIV+ prisoners.
Feaster DJ; Reznick OG; Zack B; McCartney K; Gregorich SE; Brincks AM
J Correct Health Care; 2013 Oct; 19(4):278-92. PubMed ID: 24078623
[TBL] [Abstract][Full Text] [Related]
19. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.
White BL; Golin CE; Grodensky CA; Kiziah CN; Richardson A; Hudgens MG; Wohl DA; Kaplan AH
AIDS Behav; 2015 Jan; 19(1):128-36. PubMed ID: 25055766
[TBL] [Abstract][Full Text] [Related]
20. Effect of 2 Integrated Interventions on Alcohol Abstinence and Viral Suppression Among Vietnamese Adults With Hazardous Alcohol Use and HIV: A Randomized Clinical Trial.
Go VF; Hutton HE; Ha TV; Chander G; Latkin CA; Mai NVT; Quynh BX; Nguyen V; Sripaipan T; Lancaster KE; Blackburn N; Hershow RB; Dowdy DW; Frangakis C
JAMA Netw Open; 2020 Sep; 3(9):e2017115. PubMed ID: 32945875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
